1. |
Singh AD, Turell ME, Topham AK. Uveal melanoma: trends in incidence, treatment, and survival[J]. Ophthalmology, 2011, 118(9): 1881-1885. DOI: 10.1016/j.ophtha.2011.01.040.
|
2. |
Shields CL, Kaliki S, Shah SU, et al. Iris melanoma: features and prognosis in 317 children and adults[J]. J AAPOS, 2012, 16(1): 10-16. DOI: 10.1016/j.jaapos.2011.10.012.
|
3. |
Hoefsmit EP, Rozeman EA, Van TM, et al. Comprehensive analysis of cutaneous and uveal melanoma liver metastases[J/OL]. J Immunother Cancer, 2020, 8(2): e001501[2020-12-01]. https://pubmed.ncbi.nlm.nih.gov/33262254/. DOI: 10.1136/jitc-2020-001501.
|
4. |
Kaliki S, Shields CL. Uveal melanoma: relatively rare but deadly cancer[J]. Eye (Lond), 2017, 31(2): 241-257. DOI: 10.1038/eye.2016.275.
|
5. |
张路遥, 时永全. 单细胞测序技术在消化系统肿瘤研究中的应用及进展[J]. 西南国防医药, 2020, 30(11): 1032-1035. DOI: 10.3969/j.issn.1004-0188.2020.11.019.Zhang LY, Shi YQ. Application and progress of single-cell sequencing technology in digestive system tumor research[J]. Medical Journal of National Defending Forces in Southwest China, 2020, 30(11): 1032-1035. DOI: 10.3969/j.issn.1004-0188.2020.11.019.
|
6. |
Robertson AG, Shih J, Yau C, et al. Integrative analysis identifies four molecular and clinical subsets in uveal melanoma[J]. Cancer Cell, 2018, 33(1): 151. DOI: 10.1016/j.ccell.2017.07.003.
|
7. |
Pan H, Lu L, Cui J, et al. Immunological analyses reveal an immune subtype of uveal melanoma with a poor prognosis[J]. Aging (Albany NY), 2020, 12(2): 1446-1464. DOI: 10.18632/aging.102693.
|
8. |
Zhao H, Chen Y, Shen P, et al. Identification of immune cell infiltration landscape and their prognostic significance in uveal melanoma[J/OL]. Front Cell Dev Biol, 2021, 9: 713569[2021-08-26]. https://pubmed.ncbi.nlm.nih.gov/34513843/. DOI: 10.3389/fcell.2021.713569.
|
9. |
Tang F, Barbacioru C, Wang Y, et al. mRNA-Seq whole-transcriptome analysis of a single cell[J]. Nat Methods, 2009, 6(5): 377-382. DOI: 10.1038/nmeth.1315.
|
10. |
Meacham CE, Morrison SJ. Tumour heterogeneity and cancer cell plasticity[J]. Nature, 2013, 501(7467): 328-337. DOI: 10.1038/nature12624.
|
11. |
Durante MA, Rodriguez DA, Kurtenbach S, et al. Single-cell analysis reveals new evolutionary complexity in uveal melanoma[J]. Nat Commun, 2020, 11(1): 496. DOI: 10.1038/s41467-019-14256-1.
|
12. |
Pandiani C, Strub T, Nottet N, et al. Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic disease[J]. Cell Death Differ, 2021, 28(6): 1990-2000. DOI: 10.1038/s41418-020-00730-7.
|
13. |
Strub T, Martel A, Nahon-Esteve S, et al. Translation of single-cell transcriptomic analysis of uveal melanomas to clinical oncology[J/OL]. Prog Retin Eye Res, 2021, 85: 100968[2021-04-15].https://pubmed.ncbi.nlm.nih.gov/33852963/. DOI: 10.1016/j.preteyeres.2021.100968.
|
14. |
杨芳, 于雁. 肿瘤微环境-肿瘤转移的关键因素[J]. 中国肺癌杂志, 2015, 18(1): 48-54. DOI: 10.3779/j.issn.1009-3419.2015.01.08.Yang F, Yu Y. Tumor microenvironment-the critical element of tumor metastasis[J]. Chin J Lung Cancer, 2015, 18(1): 48-54. DOI: 10.3779/j.issn.1009-3419.2015.01.08.
|
15. |
Wang Y, Xu Y, Dai X, et al. The prognostic landscape of adaptive immune resistance signatures and infiltrating immune cells in the tumor microenvironment of uveal melanoma[J/OL]. Exp Eye Res, 2020, 196: 108069[2020-05-19]. https://pubmed.ncbi.nlm.nih.gov/32439398/. DOI: 10.1016/j.exer.2020.108069.
|
16. |
Tosi A, Cappellesso R, Dei Tos AP, et al. The immune cell landscape of metastatic uveal melanoma correlates with overall survival[J]. J Exp Clin Cancer Res, 2021, 40(1): 154. DOI: 10.1186/s13046-021-01947-1.
|
17. |
Bronkhorst IH, Vu TH, Jordanova ES, et al. Different subsets of tumor-infiltrating lymphocytes correlate with macrophage influx and monosomy 3 in uveal melanoma[J]. Invest Ophthalmol Vis Sci, 2012, 53(9): 5370-5378. DOI: 10.1167/iovs.11-9280.
|
18. |
Triozzi PL, Schoenfield L, Plesec T, et al. Molecular profiling of primary uveal melanomas with tumor-infiltrating lymphocytes[J/OL]. Oncoimmunology, 2014, 8(10): e947169[2014-10-31]. https://pubmed.ncbi.nlm.nih.gov/31646061/. DOI: 10.4161/21624011.2014.947169.
|
19. |
Gezgin G, Dogrusöz M, van Essen TH, et al. Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment[J]. Cancer Immunol Immunother, 2017, 66(7): 903-912. DOI: 10.1007/s00262-017-1991-1.
|
20. |
Lin W, Beasley AB, Ardakani NM, et al. Intra-and intertumoral heterogeneity of liver metastases in a patient with uveal melanoma revealed by single-cell RNA sequencing[J/OL]. Cold Spring Harb Mol Case Stud, 2021, 7(5): a006111[2021-10-19]. https://pubmed.ncbi.nlm.nih.gov/34470851/. DOI: 10.1101/mcs.a006111.
|
21. |
Shain AH, Bagger MM, Yu R, et al. The genetic evolution of metastatic uveal melanoma[J]. Nat Genet, 2019, 51(7): 1123-1130. DOI: 10.1038/s41588-019-0440-9.
|
22. |
Bakhoum MF, Francis JH, Agustinus A, et al. Loss of polycomb repressive complex 1 activity and chromosomal instability drive uveal melanoma progression[J/OL]. Nat Commun, 2021, 12(1): 5402[2021-09-13]. https://pubmed.ncbi.nlm.nih.gov/34518527/. DOI: 10.1038/s41467-021-25529-z.
|
23. |
Medina CA, Biscotti CV, Singh N, et al. Diagnostic cytologic features of uveal melanoma[J]. Ophthalmology, 2015, 122(8): 1580-1584. DOI: 10.1016/j.ophtha.2015.04.013.
|
24. |
Amin MB, Greene FL, Edge SB, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging[J]. CA Cancer J Clin, 2017, 67(2): 93-99. DOI: 10.3322/caac.21388.
|
25. |
Ewens KG, Kanetsky PA, Richards-Yutz J, et al. Genomic profile of 320 uveal melanoma cases: chromosome 8p-loss and metastatic outcome[J]. Investig Ophthalmol Vis Sci, 2013, 54(8): 5721-5729. DOI: 10.1167/iovs.13-12195.
|
26. |
Dogrusöz M, Bagger M, Van Duinen SG, et al. The prognostic value of AJCC staging in uveal melanoma is enhanced by adding chromosome 3 and 8q status[J]. Investig Ophthalmol Vis Sci, 2017, 58(2): 833-842. DOI: 10.1167/iovs.16-20212.
|
27. |
Bagger M, Andersen MT, Andersen KK, et al. The prognostic effect of American Joint Committee on Cancer staging and genetic status in patients with choroidal and ciliary body melanoma[J]. Invest Ophthalmol Vis Sci, 2014, 56(1): 438-444. DOI: 10.1167/iovs.14-15571.
|
28. |
Onken MD, Worley LA, Ehlers JP, et al. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death[J]. Cancer Res, 2004, 64(20): 7205-7209. DOI: 10.1158/0008-5472.CAN-04-1750.
|
29. |
Field MG, Durante MA, Anbunathan H, et al. Punctuated evolution of canonical genomic aberrations in uveal melanoma[J]. Nat Commun, 2018, 9(1): 116. DOI: 10.1038/s41467-017-02428-w.
|
30. |
Li Y, Yang X, Yang J, et al. An 11-gene-based prognostic signature for uveal melanoma metastasis based on gene expression and DNA methylation profile[J]. J Cell Biochem, 2019, 120: 8630-8639. DOI: 10.1002/jcb.28151.
|
31. |
van Essen TH, van Pelt SI, Bronkhorst IH, et al. Upregulation of HLA expression in primary uveal melanoma by infiltrating leukocytes[J/OL]. PLoS One, 2016, 11(10): e0164292[2016-10-20]. https://pubmed.ncbi.nlm.nih.gov/27764126/. DOI: 10.1371/journal.pone.0164292.
|
32. |
Liu Z, Li S, Huang S, et al. N6-methyladenosine regulators and related lncRNAs are potential to be prognostic markers for uveal melanoma and indicators of tumor microenvironment remodeling[J/OL]. Front Oncol, 2021, 11: 704543[2021-07-30]. https://pubmed.ncbi.nlm.nih.gov/34395276/. DOI: 10.3389/fonc.2021.704543.
|
33. |
Bartlett EK, Fetsch PA, Filie AC, et al. Human melanoma metastases demonstrate nonstochastic site-specific antigen heterogeneity that correlates with T-cell infiltration[J]. Clin Cancer Res, 2014, 20(10): 2607-2616. DOI: 10.1158/1078-0432.CCR-13-2690.
|
34. |
Sun Y, Wu J, Yuan Y, et al. Construction of a promising tumor-infiltrating CD8+ T cells gene signature to improve prediction of the prognosis and immune response of uveal melanoma[J/OL]. Front Cell Dev Biol, 2021, 9: 673838[2021-05-28]. https://pubmed.ncbi.nlm.nih.gov/34124058/. DOI: 10.3389/fcell.2021.673838.
|
35. |
Spagnolo F, Caltabiano G, Queirolo P. Uveal melanoma[J]. Cancer Treat Rev, 2012, 38(5): 549-553. DOI: 10.1016/j.ctrv.2012.01.002.
|
36. |
Singh RK, Gupta S, Dastidar S, et al. Cysteinyl leukotrienes and their receptors: molecular and functional characteristics[J]. Pharmacology, 2010, 85(6): 336-349. DOI: 10.1159/000312669.
|
37. |
Gusach A, Luginina A, Marin E, et al. Structural basis of ligand selectivity and disease mutations in cysteinyl leukotriene receptors[J/OL]. Nat Commun, 2019, 10(1): 5573[2019-12-06]. https://pubmed.ncbi.nlm.nih.gov/31811124/. DOI: 10.1038/s41467-019-13348-2.
|
38. |
Nell RJ, Menger NV, Versluis M, et al. Involvement of mutant and wild-type CYSLTR2 in the development and progression of uveal nevi and melanoma[J]. BMC Cancer, 2021, 21(1): 164. DOI: 10.1186/s12885-021-07865-x.
|